Double-blind, Placebo-controlled, Dose-ranging Trial for the Assessment of Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single Ascending Oral Doses, and Multiple Oral Doses of GLPG0778 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2011
At a glance
- Drugs Solcitinib (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 10 Nov 2011 Results are expected before the end of 2011.
- 17 Oct 2011 Actual end date May 2011 added as reported by ClinicalTrials.gov.
- 17 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.